Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Zecuity Redesign Got Migraine Patch Through FDA, But Burning Continued

Sep 16 2016

• By Brenda Sandburg

Related Content

Allergan/MAP Planned Merger, Approval Of NuPathe’s Triptan Patch Change U.S. Landscape For Migraine Therapy

Jan 28 2013

NuPathe Must Patch Together New Zelrix Launch Timetable After "Complete Response" Letter

Aug 30 2011

Teva Wins Bidding For NuPathe And Its Migraine Patch, Topping Endo

Jan 21 2014

Zecuity Clinical Development Timeline

Sep 16 2016

Zecuity Reviewers

Sep 16 2016

Teva Zecuity's Safety: Burns Go From Non-Issue In Label To Product Puller

Jun 13 2016

Related Companies

NuPathe, Inc.

GSK plc

Teva Pharmaceutical Industries Ltd.

Additional Topics

United States Drug Review Regulation Neurology BioPharmaceutical

More from Product Reviews

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window